How Does the COVID-19 Prevention Drug Evusheld Work and Who Should Receive It?
- on Apr 12, 2022
[ad_1] While many immunocompromised and high-risk patients may benefit from AstraZeneca’s Evusheld, drug distribution and access have been uneven. The U.S. Food and Drug Administration granted emergency use authorization to AstraZeneca’s COVID-19 antibody drug Evusheld on December 8, 2021. Infectious disease physician Patrick Jackson of the University of Virginia explains how it works, who’s eligible […]Read More